Inspire Medical Systems, Inc. announced today that two additional Blue Cross Blue Shield (“BCBS”) plans will provide coverage for the Company’s Inspire therapy.
Florida Blue, part of the Blue Cross and Blue Shield (“BCBS”) Association, is the leading health insurer in Florida and covers approximately 5.9 million members, and issued their policy with an effective date of August 15, 2020.
Blue Cross and Blue Shield of Minnesota (“BCBS Minnesota”), the largest health plan in Minnesota, is an independent licensee of the BCBS Association and covers 2.7 million lives. The effective date of the policy is October 5, 2020.
“We are pleased to receive these positive coverage decisions from two more Blue Cross Blue Shield Healthcare Plans, bringing the total to 31 BCBS plans covering Inspire therapy. As health plans continue to update their coverage policies to include Inspire therapy, an increasing number of patients and physicians will have access to our innovative therapy,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. “With the addition of Florida Blue and BCBS Minnesota, we now have 58 coverage policies, representing over 190 million lives, that cover Inspire therapy.”
In addition to the 58 commercial coverage policies, Inspire therapy also has Medicare coverage across the entire United States.
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
